Position in VIR
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$4,907,866
+$2,190,780 QoQ
Shares Held
547,753
+21.6% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. VIR ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in VIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,907,866 | 547,753 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,717,086 | 450,595 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $2,602,046 | 455,700 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,313,550 | 459,038 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,976,503 | 459,337 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $3,283,276 | 447,313 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $3,231,268 | 431,411 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $3,868,171 | 434,626 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $4,680,363 | 462,030 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $5,106,727 | 507,627 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $4,794,553 | 511,692 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $11,576,442 | 471,930 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $11,136,695 | 478,586 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $12,373,146 | 488,864 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $9,268,782 | 480,746 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $12,020,184 | 471,935 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $669,516 | 26,031 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $1,083,511 | 25,878 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,672,908 | 38,440 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $1,870,302 | 39,558 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $1,066,138 | 39,811 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $1,074,768 | 31,307 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,286,170 | 31,393 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||